Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines

Live viral vectors that express heterologous antigens of the target pathogen are being investigated in the development of novel vaccines against serious infectious agents like HIV and Ebola. As some live recombinant vectored vaccines may be replication-competent, a key challenge is defining the leng...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccine
Autori principali: Kochhar, Sonali, Excler, Jean-Louis, Bok, Karin, Gurwith, Marc, McNeil, Michael M., Seligman, Stephen J., Khuri-Bulos, Najwa, Klug, Bettina, Laderoute, Marian, Robertson, James S., Singh, Vidisha, Chen, Robert T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Authors. Published by Elsevier Ltd. 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535369/
https://ncbi.nlm.nih.gov/pubmed/30497831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.08.085
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi